Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

January 31, 2008

Conditions
Breast Cancer
Interventions
GENETIC

proteomic profiling

at the time of each procedure.

PROCEDURE

lumpectomy or mastectomy

removal of breast tumor or removal of the entire breast in which the tumor is located

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

Prior to initiation of treatment

PROCEDURE

histopathologic examination

After the breast tumor has been removed, examination of the tumor under a microscope to determine the type and grade of breast cancer

PROCEDURE

magnetic resonance spectroscopy

Prior to initiation of treatment

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT00656604 - Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | Biotech Hunter | Biotech Hunter